The historical rank and industry rank for Nascent Pharma Holdings's Days Inventory or its related term are showing as below:
NASC's Days Inventory is not ranked *
in the Drug Manufacturers industry.
Industry Median: 162.83 * Ranked among companies with meaningful Days Inventory only.
Nascent Pharma Holdings's Days Inventory
declined
from Sep. 2023 (92.80) to Sep. 2024 (78.86).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Nascent Pharma Holdings's Inventory Turnover for the
three
months ended in Sep. 2024 was 1.16.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Nascent Pharma Holdings's Inventory-to-Revenue for the
three
months ended in Sep. 2024 was 23.97.
Nascent Pharma Holdings (OTCPK:NASC) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Nascent Pharma Holdings's Inventory Turnover for the
three
months ended in Sep. 2024 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Nascent Pharma Holdings's Inventory to Revenue for the
three
months ended in Sep. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Nascent Pharma Holdings Days Inventory Related Terms
Nascent Pharma Holdings Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NASC vs ALID, CPMD, PLSH: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Nascent Pharma Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nascent Pharma Holdings Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Nascent Pharma Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Nascent Pharma Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nascent Pharma Holdings (NASC) has a Days Inventory of 78.86 as of Sep. 2024. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Nascent Pharma Holdings and its competitors.
Is Nascent Pharma Holdings' Days Inventory too high?
Nascent Pharma Holdings' current Days Inventory is 78.86. The Drug Manufacturers industry median Days Inventory is 162.83. Nascent Pharma Holdings' value of 78.86 is 51.6% below this industry median. Overall, Nascent Pharma Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Nascent Pharma Holdings' Days Inventory compare to ALID and CPMD?
Nascent Pharma Holdings' Days Inventory of 78.86 can be compared against companies in the Drug Manufacturers industry. The industry median Days Inventory is 162.83. Nascent Pharma Holdings' value of 78.86 is 51.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 162.83, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nascent Pharma Holdings's current Days Inventory of 78.86 is 51.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Nascent Pharma Holdings and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 162.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nascent Pharma Holdings's current Days Inventory is 78.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nascent Pharma Holdings stock overvalued right now?
Nascent Pharma Holdings (NASC) has a current Days Inventory of 78.86. The current Days Inventory is 78.86 and 51.6% below the Drug Manufacturers industry median of 162.83. Nascent Pharma Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Nascent Pharma Holdings (NASC), the current Days Inventory is 78.86 as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nascent Pharma Holdings Inc has acquired a Subsidiary engaged in enforcing and commercializing the patents held by Nascent. The acquired patents cover liquid formulations of cannabis. The patents relate to the extraction of pharmaceutically active components from plant materials, and more particularly to the preparation of a botanical drug substance for incorporation into a medicament and for use in pharmaceutical formulations, in particular comprising cannabinoids obtained from cannabis. Patented uses include using the liquid formulations to alleviate numerous debilitating conditions, including cancer, irritable bowel syndrome, chronic pain, post-traumatic stress disorder, anxiety, sleep disorders, and opioid dependencies.
12GF Score
Get the complete analysis for NASC
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NASC has been successfully added to your 
